Rocket Pharmaceuticals (RCKTW) News Today $0.04 0.00 (-3.25%) Closing price 07/11/2025 07:00 AM EasternExtended Trading$0.04 0.00 (0.00%) As of 07/11/2025 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock RCKTW Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Former Laval Rocket Defenseman Noel Hoefenmayer Signs In Russia3 hours ago | sports.yahoo.comShareholders that lost money on Rocket Pharmaceuticals, Inc.(RCKT ...July 12 at 9:14 PM | morningstar.comMCramer's Lightning Round: Rocket Lab is a buyJuly 12 at 6:11 AM | msn.comCivilian astronaut, Space Camp alum announces $15 million donation to U.S. Space & Rocket CenterJuly 12 at 6:11 AM | msn.comFormer Houston Rocket Jalen Green not surprised by being traded to Phoenix Suns. 'I had a feeling'July 12 at 6:11 AM | msn.comRCKT Investors Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit - MorningstarJuly 9, 2025 | morningstar.comMBrabus Rocket GTS Deep Blue Is A Carbon Fiber Clownshoe With A Thousand HorsepowerJuly 8, 2025 | msn.com2025-07-01 | Investor Alert: Deadline Approaching to Join Rocket Pharmaceuticals, Inc. (RCKT) Class Action - Contact Levi & Korsinsky | NDAQ:RCKT | Press Release - StockhouseJuly 3, 2025 | stockhouse.com2025-07-01 | Investors in Rocket Pharmaceuticals, Inc. (RCKT): Protect Your Rights - Contact Levi & Korsinsky Before August 11, 2025 | NDAQ:RCKT | Press Release - StockhouseJuly 3, 2025 | stockhouse.comRocket Pharmaceuticals stock rises after FDA clearance for heart failure therapyJune 30, 2025 | investing.comRocket Pharmaceuticals receives FDA clearance of RP-A701June 30, 2025 | msn.comRocket Pharmaceuticals Shares Gain on FDA Green Light for Gene Therapy Targeting Heart FailureJune 30, 2025 | msn.comDavis Thompson makes incredible 3 eagles in 8 holes in Round 3 of Rocket ClassicJune 28, 2025 | msn.com2025 Rocket Classic picks, odds, field: Surprising predictions from golf model that's nailed 15 majorsJune 26, 2025 | msn.comRocket Classic leaderboard for Round 1: Start time, tee times, TV channel, streamingJune 26, 2025 | msn.comLaw Offices of Frank R. Cruz Encourages Rocket Pharmaceuticals, Inc. (RCKT) Investors To Inquire About Securities Fraud Class Action - Business WireJune 24, 2025 | businesswire.comRocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA’s Clinical Hold on Gene Therapy Trial – Hagens Berman - MorningstarJune 24, 2025 | morningstar.comMSecurities Fraud Investigation Into Rocket Pharmaceuticals, Inc. (RCKT) Announced - Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities ...June 21, 2025 | tmcnet.comRocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationJune 21, 2025 | morningstar.comMSecurities Fraud Investigation Into Rocket Pharmaceuticals, Inc. (RCKT) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading ...June 21, 2025 | businesswire.comRocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud InvestigationJune 20, 2025 | tmcnet.comRocket Classic 2025 field: Former U.S. Open champion Matt Fitzpatrick commits to DetroitJune 10, 2025 | msn.comWhy Space Stock Rocket Lab Soared TodayJune 10, 2025 | fool.comEvercore ISI Downgrades Rocket Pharmaceuticals (RCKT) Stock, Slashes PTJune 2, 2025 | msn.comLeerink Partners Downgrades Rocket Pharmaceuticals (RCKT) to Market Perform on Danon Disease BlowMay 29, 2025 | msn.comWilliam Blair Reaffirms Outperform Rating on Rocket Pharma Despite Trial SetbackMay 29, 2025 | msn.comRocket Pharmaceuticals: Despite FDA Clinical Hold On RP-A501, Prospects Remain IntactMay 29, 2025 | seekingalpha.comLeerink Partners Downgrades Rocket Pharmaceuticals (RCKT)May 29, 2025 | msn.comNeedham Downgrades Rocket Pharmaceuticals (RCKT)May 28, 2025 | msn.comRocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient DeathMay 27, 2025 | msn.comCoreWeave, Rocket Pharmaceuticals, SoundHound: Trending TickersMay 27, 2025 | finance.yahoo.comFDA halts Rocket Pharma's gene therapy trial as patient diesMay 27, 2025 | msn.comRocket Pharmaceuticals Stock Drops Pre-Market After FDA Pauses Gene Therapy Trial Over Patient Death: Retail Turns BullishMay 27, 2025 | msn.comRocket Pharmaceuticals Stock Craters After Gene Therapy Patient DiesMay 27, 2025 | msn.comRocket Pharmaceuticals stock tumbles after patient death halts trialMay 27, 2025 | za.investing.comRocket Pharmaceuticals Shares Down as Trial Patient Dies of ComplicationsMay 27, 2025 | marketwatch.comRocket Pharma plunges after FDA clinical hold on mid-stage trialMay 27, 2025 | msn.comRocket Pharmaceuticals Provides Update on Phase 2 Clinical Trial of RP-A501 for Danon DiseaseMay 27, 2025 | finance.yahoo.comUS FDA pauses gene therapy trial by Rocket Pharma after patient deathMay 27, 2025 | msn.comRocket Pharmaceuticals Presents Preliminary Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy at 28th Annual Meeting of the American Society of ...May 17, 2025 | businesswire.comRocket Pharma's Gene Therapy Shows Promise in ACM Patients, Says AnalystMay 16, 2025 | benzinga.comRocket Companies and UWM take losses yet remain hopeful amid economic uncertaintyMay 9, 2025 | msn.comRocket posts net loss in first quarterMay 9, 2025 | detroitnews.comDFINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Lab USAApril 28, 2025 | tmcnet.comIs Rocket Pharmaceuticals (NASDAQ:RCKT) In A Good Position To Deliver On Growth Plans?April 17, 2025 | finance.yahoo.comRocket Lab Shares Rise After Selection to Participate in US, UK Military ProgramsApril 14, 2025 | marketwatch.comRocket Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare ConferenceApril 3, 2025 | finance.yahoo.comRocket acquires Mr. Cooper in $9.4 billion mergerMarch 31, 2025 | msn.comRocket Lab nets major Pentagon contractMarch 29, 2025 | msn.comRocket Lab USA Shares Rise After DoD Selection to Compete for LaunchesMarch 28, 2025 | marketwatch.com Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKTW and its competitors with MarketBeat's FREE daily newsletter. Email Address RCKTW Media Mentions By Week RCKTW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCKTW News Sentiment▼0.270.99▲Average Medical News Sentiment RCKTW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCKTW Articles This Week▼83▲RCKTW Articles Average Week Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKTW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AIMDW News BCTXW News COCP News ENGNW News FBIOP News GOVXW News INDV News JSPRW News LEXXW News MEIP News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RCKTW) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.